BOTHELL, Wash., Oct. 2 /PRNewswire/ -- Diagnostic Ultrasound Corporation is pleased to announce that it has once again been ranked in the prestigious Technology Fast 50 Program for Washington State, a ranking of the 50 fastest growing technology companies in the area by Deloitte & Touche LLP, one of the nation's leading professional services organizations. Rankings are based on percentage revenue growth over a five-year period from 2001-2005. This is the third time in the past five years that Diagnostic Ultrasound has been ranked in Deloitte's Fast 50.
(Logo: http://www.newscom.com/cgi-bin/prnh/20010503/SFTH003LOGO-b )
"It has been an exciting year for us with the acquisition of Saturn Biomedical Systems and the GlideScope(R) brand," said Gerald McMorrow, CEO of Diagnostic Ultrasound Corporation. "Our continuing growth is directly tied to our exceptional team of employees worldwide. I would like to thank our loyal customers for working to improve patient care, our shareholders who have trusted us, and our fine team of employees for providing excellence to our customers."
"Sustaining high revenue growth for five years is an exceptional accomplishment," said Larry Hile, a Partner in Deloitte's Technology, Media & Telecommunications (TMT) industry practice based in Seattle. "We commend Diagnostic Ultrasound Corporation for making the commitment to technology and delivering on the promise of market longevity. We are proud to honor Diagnostic Ultrasound as a Deloitte Technology Fast 50 winner."
Diagnostic Ultrasound designs and manufactures reliable, state-of-the-art medical devices and services that offer a meaningful improvement in patient care to the health care community. The company is best know for its BladderScan(R) brand, a line of noninvasive bladder volume measurement instruments used in Urology, Acute Care, Primary Care, and Extended Care. BladderScan(R) helps diagnose urinary-related problems such as enlarged prostate (BPH), and is clinically proven to prevent unnecessary urinary catheterizations and reduce rates of urinary tract infection. The company recently expanded its product portfolio with the acquisition of Saturn Biomedical Systems and the GlideScope(R) Video Laryngoscope (GVL(R)) brand in January 2006. GlideScope(R) provides a consistently clear view of the airway, enabling quick intubation, and offers significant benefits to Anesthesiology, Critical Care, and Emergency Medicine professionals.
To qualify for the Technology Fast 50, companies must have had operating revenues of at least $50,000 in 2001 and $5,000,000 in 2005, be headquartered in North America, and be a company that owns proprietary technology or proprietary intellectual property that contributes to a significant portion of the company's operating revenues; or devotes a significant proportion of revenues to the research and development of technology. Using other companies' technology or intellectual property in a unique way does not qualify.
Winners of the 16 regional Technology Fast 50 programs in the United States and Canada are automatically entered in Deloitte's Technology Fast 500 program, which ranks North America's top 500 fastest growing technology, media, telecommunications and life sciences companies. For more information on Deloitte's Technology Fast 50 or Technology Fast 500 programs, visit www.fast500.com .
About Diagnostic Ultrasound
Diagnostic Ultrasound provides pioneering and reliable medical devices and services that offer a meaningful improvement in patient care to the health care community. The company's noninvasive BladderScan(R) instrument is the standard of care for bladder volume measurement. The BladderScan(R) brand is found in Urology and Primary Care practices, as well as Acute and Extended Care facilities in over 60 countries. With the January 2006 acquisition of Saturn Biomedical Systems in Vancouver, Canada, Diagnostic Ultrasound entered Anesthesiology, Critical Care, and Emergency markets with the GlideScope(R) Video Laryngoscope (GVL(R)) brand. Recently experiencing double-digit growth, Diagnostic Ultrasound was ranked among the fastest growing technology companies in Washington State in Deloitte's prestigious "Technology Fast 50" program for both 2005 and 2006. Diagnostic Ultrasound is headquartered in Bothell, Washington and has approximately 200 employees worldwide. For more information, please visit www.dxu.com .
About Deloitte
Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, its member firms and their respective subsidiaries and affiliates. As a Swiss Verein (association), neither Deloitte Touche Tohmatsu nor any of its member firms has any liability for each other's acts or omissions. Each of the member firms is a separate and independent legal entity operating under the names "Deloitte", "Deloitte & Touche", "Deloitte Touche Tohmatsu" or other related names. Services are provided by the member firms or their subsidiaries or affiliates and not by the Deloitte Touche Tohmatsu Verein.
Deloitte & Touche USA LLP is the US member firm of Deloitte Touche Tohmatsu. In the US, services are provided by the subsidiaries of Deloitte & Touche USA LLP (Deloitte & Touche LLP, Deloitte Consulting LLP, Deloitte Financial Advisory Services LLP, Deloitte Tax LLP and their subsidiaries), and not by Deloitte & Touche USA LLP.
NOTE: BladderScan(R), GlideScope(R) and GVL(R) are registered trademarks of Diagnostic Ultrasound Corp. in the United States and/or other countries.
Media Contact: Jessica McMorrow, PR Specialist, Diagnostic Ultrasound Corp., 425-867-1348, Ext. 6062. Alternate Contact: Jessica McNerney, Executive Assistant to Gerald McMorrow, Diagnostic Ultrasound Corp., 425-867-1348, ext. 1448.
Photo: http://www.newscom.com/cgi-bin/prnh/20010503/SFTH003LOGO-bAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comDiagnostic Ultrasound CorporationCONTACT: Jessica McMorrow, PR Specialist, +1-425-867-1348, ext. 6062 orJessica McNerney, Executive Assistant to Gerald McMorrow, +1-425-867-1348,ext. 1448., both of Diagnostic Ultrasound Corp.
